The impact of COVID-19 on ALL patients in Spain

Share :
Published: 22 Jul 2020
Views: 2450
Dr Josep Ribera - Catalan Institute of Oncology, Barcelona, Spain

Dr Josep Ribera speaks to ecancer in online video interview about the management of acute lymphoblastic leukaemia patients (ALL) during the coronavirus pandemic.

He speaks about a recent survey he carried out during the peak of the pandemic, which assessed the impact of COVID-19 on patients with ALL in Spain.

Dr Ribera explains the results of the survey, and states that the incidence of COVID-19 and ALL subtype were not linked, but notes that elderly patients were more affected.

He also outlines the main changes to treatment practices during the pandemic - in particular stem cell transplantations.

ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.